Legal status in the United States
Is HGH legal?
Read at FDA, DEA and WADAPublished by PepVault
HGH (somatropin) is FDA-approved (Humatrope, first in 1986), is not a federally controlled substance (though federal law, 21 U.S.C. 333(e), makes distributing it for uses FDA hasn’t authorized a crime), and is banned in sport (WADA names it under S2.2.3), as of November 18, 2026.
HGH at a glance
| Check | Status, read Nov 18, 2026 |
|---|---|
| FDA approval | Approved (Humatrope, 1986) |
| Compounding | A biologic; FDA: not eligible for 503A or 503B |
| DEA schedule | Not controlled |
| Other federal law | A crime to distribute for unapproved uses (21 U.S.C. 333(e)) |
| Sport (WADA) | Banned, named (S2.2.3) |
FDA approval
Somatropin, recombinant human growth hormone, is FDA-approved under many brands; Drugs@FDA’s earliest somatropin approval is Humatrope, in 1986, and later brands include Genotropin (1995), Norditropin (2000) and Omnitrope (2006).
Humatrope (injection)
Approved for growth failure in children who make too little growth hormone and several other causes of short stature, and growth hormone deficiency in adults. BLA 019640, first approved October 16, 1986.
- Drugs@FDA: Humatrope, application 019640, U.S. Food and Drug Administration. Read .
- Humatrope prescribing information on DailyMed, National Library of Medicine (DailyMed). Read .
- Drugs@FDA: Humatrope, application 019640, U.S. Food and Drug Administration. Read .
- Drugs@FDA data (openFDA): applications listing “SOMATROPIN” as an active ingredient, U.S. Food and Drug Administration. Read .
- Drugs@FDA: Genotropin, application 020280, U.S. Food and Drug Administration. Read .
- Drugs@FDA: Norditropin, application 021148, U.S. Food and Drug Administration. Read .
- Drugs@FDA: Omnitrope, application 021426, U.S. Food and Drug Administration. Read .

Compounding
Drugs@FDA lists somatropin as a biologic (Humatrope, BLA 019640, and the other brands), and FDA writes that biological products “are not eligible for the exemptions for compounded drugs under sections 503A and 503B”.
The source: “Biological products are not eligible for the exemptions for compounded drugs under sections 503A and 503B of the FD&C Act.”
- Compounding and the FDA: Questions and Answers (content current as of September 16, 2025), U.S. Food and Drug Administration. Read .
DEA schedule
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
The source: “Human growth hormone is not controlled under the Controlled Substances Act.”
- 21 CFR Part 1308, Schedules of Controlled Substances (eCFR, up to date as of November 16, 2026), Electronic Code of Federal Regulations. Read .
- Controlled Substances, Alphabetical Order (dated November 17, 2026), Drug Enforcement Administration, Diversion Control Division. Read .
- Human Growth Hormone, drug and chemical information (July 2026), Drug Enforcement Administration, Diversion Control Division. Read .
Other federal law: 21 U.S.C. 333(e)
Federal law has a rule of its own for human growth hormone. Section 333(e) of the Food, Drug, and Cosmetic Act makes it a crime to knowingly distribute it, or possess it with intent to distribute, for any use in humans other than treating a disease or recognized condition where FDA has authorized that use and a physician has ordered it: up to 5 years in prison, or 10 where someone under 18 is involved. The law defines human growth hormone as somatrem, somatropin or an analogue of either, and the DEA investigates these offenses.
The source: “whoever knowingly distributes, or possesses with intent to distribute, human growth hormone for any use in humans other than the treatment of a disease or other recognized medical condition”
- 21 U.S.C. 333, Penalties (United States Code, 2024 edition), U.S. Government Publishing Office (govinfo). Read .
- Human Growth Hormone, drug and chemical information (July 2026), Drug Enforcement Administration, Diversion Control Division. Read .
Sport (WADA)
WADA bans growth hormone at all times, in and out of competition: S2.2.3 of the 2026 list names it, with its analogues and fragments.
The source: “Growth hormone (GH), its analogues and fragments”
- World Anti-Doping Code International Standard, Prohibited List 2026 (in effect from January 1, 2026), World Anti-Doping Agency. Read .
What this means and doesn’t
This page reports what the agencies’ own pages said about HGH in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.
It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.
Questions
Is HGH FDA approved?
Somatropin, recombinant human growth hormone, is FDA-approved under many brands; Drugs@FDA’s earliest somatropin approval is Humatrope, in 1986, and later brands include Genotropin (1995), Norditropin (2000) and Omnitrope (2006).
Is HGH a controlled substance?
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances. Federal law has a rule of its own for human growth hormone. Section 333(e) of the Food, Drug, and Cosmetic Act makes it a crime to knowingly distribute it, or possess it with intent to distribute, for any use in humans other than treating a disease or recognized condition where FDA has authorized that use and a physician has ordered it: up to 5 years in prison, or 10 where someone under 18 is involved. The law defines human growth hormone as somatrem, somatropin or an analogue of either, and the DEA investigates these offenses.
Is HGH banned in sport?
WADA bans growth hormone at all times, in and out of competition: S2.2.3 of the 2026 list names it, with its analogues and fragments.
What does FDA say about compounding HGH?
Drugs@FDA lists somatropin as a biologic (Humatrope, BLA 019640, and the other brands), and FDA writes that biological products “are not eligible for the exemptions for compounded drugs under sections 503A and 503B”.